We used the BCR/ABL1+ KU812 cell line, a widely used system for the study of molecular mechanisms underlying CML pathogenesis (Kishi, 1985; Blom et al, 1992). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.